EBIT (Annual)

EBIT: Income before interest and taxes.

Ryman Healthcare Ltd. Unsponsored ADR (RYHTY) had EBIT of $-23.07M for the most recently reported fiscal year, ending 2025-03-31.

Quarterly Annual

Figures for fiscal year ending 2025-03-31

Income Statement Financials
Revenue	$451.70M
Net Income	$-259.39M
Cost of Goods Sold	$446.00M
Gross Profit	$5.70M
Operating Expenses	$474.78M
Operating Income	$-23.07M
Non-Operating Income/Expense	$-104.82M
Pre-Tax Income	$-127.90M
Normalized Pre-Tax Income	$-25.21M
Income after Taxes	$-259.39M
Income from Continuous Operations	$-259.39M
Consolidated Net Income/Loss	$-259.39M
Normalized Income after Taxes	$-262.28M
EBIT	$-23.07M
EBITDA	$3.40M
Weighted-Average Shares Outstanding (Basic)	142.04M
Weighted-Average Shares Outstanding (Diluted)	142.04M
Earnings per Share (EPS) (Basic)	$-1.83
Earnings per Share (EPS) (Diluted)	$-1.83
Balance Sheet Financials
Current Assets	$109.55M
Property, Plant, and Equipment	$605.44M
Long-Term Assets	$7.05B
Total Assets	$7.16B
Current Liabilities	$528.37M
Long-Term Debt	$1.01B
Long-Term Liabilities	$4.10B
Total Liabilities	$4.63B
Common Equity	$2.53B
Tangible Shareholders Equity	$2.52B
Shareholders Equity	$2.53B
Common Shares Outstanding	202.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$243.61M
Cash Flow from Investing Activities	$-312.09M
Cash Flow from Financial Activities	$54.14M
Beginning Cash	$24.83M
End Cash	$10.49M
Increase/Decrease in Cash	$-14.34M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.21
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.40
Gross Margin	1.26%
Operating Margin	-5.11%
EBIT Margin	-5.11%
EBITDA Margin	0.75%
Pre-Tax Profit Margin	-28.31%
Profit Margin	-57.43%
Free Cash Flow	$-37.47M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.06M
Receiveable Turnover	4.64
Days Sales in Receivables	78.65
Return on Equity	-10.25%
Return on Tangible Equity	-10.28%
Return on Assets	-3.62%
Return on Investments	-7.33%
Book Value Per Share	$12.47
Free Cash Flow per Share	$-0.26
Operating Cash Flow per Share	$1.72

Data from Zacks Investment Research, Inc.